In the last decade, protocol design has become increasingly complex with significantly more endpoints, inclusion/exclusion criteria and distinct procedures. Still, research staff are heavily reliant on paper and desktop computers to access the protocol instruction. Ken Getz, deputy director for the Tufts Center for the Study of Drug Development (CSDD) presents the current state of protocol design and complexity facing investigative research staff.
Full results are available in the new report Tufts CSDD - Teckro 2020 Study on Investigative Site Protocol Administration Referencing Practices. To request a copy, please complete the form below.
Ken originally presented this segment in a longer webinar addressing clinical trial inclusion and diversity titled "No One Left Behind: Addressing Clinical Trial Access and Issues Blocking Physician Participation."